Skip to main content
. 2021 Dec 5;13(12):2090. doi: 10.3390/pharmaceutics13122090

Figure 2.

Figure 2

Schematic representation of Extra- and Intracellular Barriers for nucleic acids delivery. (I)—Endo and exonuclease degradation; (II)—Interaction and binding with erythrocytes; (III)—Binding and aggregation via serum protein complexation; (IV)—Immune activation to delivered nucleic acids.